JP2010526826A5 - - Google Patents

Download PDF

Info

Publication number
JP2010526826A5
JP2010526826A5 JP2010507665A JP2010507665A JP2010526826A5 JP 2010526826 A5 JP2010526826 A5 JP 2010526826A5 JP 2010507665 A JP2010507665 A JP 2010507665A JP 2010507665 A JP2010507665 A JP 2010507665A JP 2010526826 A5 JP2010526826 A5 JP 2010526826A5
Authority
JP
Japan
Prior art keywords
formula
composition
pharmaceutically acceptable
stereoisomer
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010507665A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010526826A (ja
JP5651009B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/063082 external-priority patent/WO2008141097A2/en
Publication of JP2010526826A publication Critical patent/JP2010526826A/ja
Publication of JP2010526826A5 publication Critical patent/JP2010526826A5/ja
Application granted granted Critical
Publication of JP5651009B2 publication Critical patent/JP5651009B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010507665A 2007-05-09 2008-05-08 治療用化合物 Expired - Fee Related JP5651009B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US92842907P 2007-05-09 2007-05-09
US92829607P 2007-05-09 2007-05-09
US92832707P 2007-05-09 2007-05-09
US60/928,296 2007-05-09
US60/928,327 2007-05-09
US60/928,429 2007-05-09
PCT/US2008/063082 WO2008141097A2 (en) 2007-05-09 2008-05-08 Stereoisomers propofol therapeutic compounds

Publications (3)

Publication Number Publication Date
JP2010526826A JP2010526826A (ja) 2010-08-05
JP2010526826A5 true JP2010526826A5 (enExample) 2011-06-23
JP5651009B2 JP5651009B2 (ja) 2015-01-07

Family

ID=39798084

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010507665A Expired - Fee Related JP5651009B2 (ja) 2007-05-09 2008-05-08 治療用化合物

Country Status (22)

Country Link
US (4) US8071818B2 (enExample)
EP (4) EP2292577A1 (enExample)
JP (1) JP5651009B2 (enExample)
KR (1) KR20100017436A (enExample)
CN (1) CN101715437B (enExample)
AT (1) ATE487685T1 (enExample)
AU (1) AU2008251482C1 (enExample)
BR (1) BRPI0811220A2 (enExample)
CA (1) CA2685570A1 (enExample)
DE (1) DE602008003431D1 (enExample)
DK (2) DK2146946T3 (enExample)
ES (1) ES2501592T3 (enExample)
HR (1) HRP20140896T1 (enExample)
IL (1) IL201795A0 (enExample)
MX (1) MX2009012124A (enExample)
NZ (1) NZ580752A (enExample)
PL (2) PL2301908T3 (enExample)
PT (1) PT2146946E (enExample)
RU (1) RU2470908C2 (enExample)
SI (1) SI2301908T1 (enExample)
WO (1) WO2008141097A2 (enExample)
ZA (1) ZA201007603B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2292577A1 (en) 2007-05-09 2011-03-09 Pharmacofore, Inc. (+)-stereoisomer of 2,6-di-sec-butylphenol and analogs thereof
JP5924539B2 (ja) * 2010-08-03 2016-05-25 学校法人 久留米大学 実験用小動物の脳波測定用装置及び脳波測定方法
CN102731265B (zh) * 2012-06-12 2014-12-10 四川百利药业有限责任公司 一种高纯度丙泊酚的制备方法
US11331271B2 (en) * 2016-05-27 2022-05-17 The Johns Hopkins University Buccal, sublingual and intranasal delivery of fospropofol
RU2635532C1 (ru) * 2016-09-06 2017-11-13 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ профилактики ажитационного синдрома у детей с онкологической патологией
CN115708819A (zh) * 2022-11-24 2023-02-24 中国科学院深圳先进技术研究院 丙泊酚的抗焦虑制药用途及抗焦虑药物制剂

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US237213A (en) 1881-02-01 William j
US2747982A (en) * 1955-05-11 1956-05-29 Dow Chemical Co Method and composition for the control of the growth of vegetation
US4798846A (en) 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
GB1472793A (en) 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
SU1525139A1 (ru) * 1987-11-10 1989-11-30 Куйбышевский политехнический институт им.В.В.Куйбышева Способ получени о-втор-бутилфенола
ES2087019B1 (es) * 1994-02-08 1997-03-16 Bobel246 S L Uso de derivados de fenoles 2,4-disubstituidos como inhibidores de la 5-lipoxigenasa.
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
US5731355A (en) * 1994-03-22 1998-03-24 Zeneca Limited Pharmaceutical compositions of propofol and edetate
US6254853B1 (en) 1998-05-08 2001-07-03 Vyrex Corporation Water soluble pro-drugs of propofol
US6204257B1 (en) 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
JP2002537243A (ja) 1999-02-18 2002-11-05 スーパージェン インコーポレイテッド ホスホコリン結合プロドラッグ誘導体
US6716452B1 (en) 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6362234B1 (en) 2000-08-15 2002-03-26 Vyrex Corporation Water-soluble prodrugs of propofol for treatment of migrane
US20020099013A1 (en) 2000-11-14 2002-07-25 Thomas Piccariello Active agent delivery systems and methods for protecting and administering active agents
US7144877B2 (en) 2000-10-06 2006-12-05 Xenoport, Inc. Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
EP1383445A4 (en) * 2001-03-20 2005-04-13 Cydex Inc FORMULATIONS WITH PROPOFOL AND A SULFOALKYL ETHER CYCLODEXTRIN
US20050042280A1 (en) 2001-12-28 2005-02-24 Rogers Tracey L. Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
WO2003077902A1 (en) 2002-02-19 2003-09-25 Xenoport, Inc. Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
BR0308857A (pt) 2002-04-08 2005-01-04 Guilford Pharm Inc Composições farmacêuticas contendo promedicamentos de propofol, solúveis em água, e métodos de administrar os mesmos
DE60323756D1 (de) 2002-10-08 2008-11-06 Fresenius Kabi De Gmbh Pharmazeutisch aktive oligosaccharid-conjugate
DE20215415U1 (de) 2002-10-08 2004-02-26 Biotechnologie Gesellschaft Mittelhessen Mbh Wasserlösliche Medikamentenvorstufen von Propofol
ZA200504940B (en) 2003-01-28 2006-09-27 Xenoport Inc Amino acid derived prodrugs of propofol, compositions and uses thereof
AU2003901815A0 (en) 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
US7230003B2 (en) 2003-09-09 2007-06-12 Xenoport, Inc. Aromatic prodrugs of propofol, compositions and uses thereof
US20070043121A1 (en) * 2003-09-29 2007-02-22 Brown Milton L Discovery of novel soluble crystalline anesthetics
WO2006017351A1 (en) 2004-07-12 2006-02-16 Xenoport, Inc. Prodrugs of propofol, compositions and uses thereof
US20080214508A1 (en) 2004-09-17 2008-09-04 Mgi Gp, Inc. Methods of Administering Water-Soluble Prodrugs of Propofol
JP2008525501A (ja) 2004-12-23 2008-07-17 ゼノポート,インコーポレイティド セリンアミノ酸誘導のプロポフォールのプロドラッグ、その使用及び結晶体
DE102005033496A1 (de) * 2005-07-19 2007-01-25 Bayer Healthcare Ag Desinfektionsmittel
JP5537033B2 (ja) * 2005-12-19 2014-07-02 ザ ユニヴァーシティー オブ リヴァプール 無痛覚
US7535698B2 (en) 2006-03-07 2009-05-19 Panasonic Corporation Case, portable information equipment using the same and manufacturing method of the case
US7731356B1 (en) * 2006-07-24 2010-06-08 Daniel Ayers Gilbert Hanging eyeglasses
EP2292577A1 (en) 2007-05-09 2011-03-09 Pharmacofore, Inc. (+)-stereoisomer of 2,6-di-sec-butylphenol and analogs thereof
AU2008251484A1 (en) 2007-05-09 2008-11-20 Pharmacofore, Inc. Therapeutic compounds

Similar Documents

Publication Publication Date Title
JP2010526827A5 (enExample)
RU2009145541A (ru) Терапевтические соединения
JP2010526826A5 (enExample)
JP2009542613A5 (enExample)
JP2017533964A5 (enExample)
JP2013545730A5 (enExample)
RU99112115A (ru) Энантиомерно чистые основные эфиры арил-циклоалкилгидроксикарбоновых кислот, способ их получения и применение в лекарственных средствах
JP2012530779A5 (enExample)
JP2010520306A5 (enExample)
JP2010270124A5 (enExample)
RU2011119990A (ru) Циклоалкиламины в качестве ингибиторов повторного поглощения моноамина
JP2012504133A5 (enExample)
JP2009143956A5 (enExample)
JP2010520308A5 (enExample)
JP2010138190A5 (enExample)
JP2005529840A5 (enExample)
JP2011518202A5 (enExample)
CN1311673A (zh) 治疗咳嗽的组合物和方法
CN101045041A (zh) 含布洛芬的巴布剂及其制备方法和应用
JP2011507896A5 (enExample)
JP2013509441A5 (enExample)
JP2008533007A5 (enExample)
JP2011527333A5 (enExample)
JP2012510985A5 (enExample)
CN1210260C (zh) 氟伐他汀钠的晶形